Avita Medical Ltd (RCEL) is a Healthcare · Medical Devices company listed on NASDAQ. Price $11.03 (-1.69%), Market cap $0.13B, 52-week low–high $3.27 ~ $6.76.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a l
Financial statements, price targets, institutional (13F) holdings and related news for Avita Medical Ltd are updated in real time on BlackAll Trade.
Avita Medical Ltd trades at $11.03 (-1.69%). Real-time quotes and charts are available on BlackAll Trade.
Avita Medical Ltd has a market cap of about $0.13B.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company'